Who knows more about treating MR than the professionals who devote their careers to it?
At Valtech, we work hand-in-hand with some of the world’s leading heart specialists. Needless to say, when people with their knowledge and experience have something to say, we listen very closely.
Karl-Heinz Kuck, M.D.
Head of Cardiology department
ASKLEPIOS Klinik St. Georg, Hamburg
For me the Cardioband is the only technology that can reproducibly reduce the septo-lateral diameter.
Cardioband is a major step forward in the history of mitral valve disease and treatment."
Michael Mack, M.D.
Medical Director, Cardiovascular Surgery
Baylor Health Care System
The evolution and success of Cardioband has worked to move this field forward and is based on common surgical practice of performing an annuloplasty in patients with FMR. Early results of research has indicated that transcatheter surgical annuloplasty using Cardioband Annuloplasty System may be a viable treatment option.
This is a novel technology which may ultimately allow patient selection at earlier stages of heart failure for treatment."
Francesco Maisano, M.D.
Klinik für Herz- und Gefässchirurgie
Georg Nickenig, M.D.
Med. Klinik und Poliklinik II
Cardioband is a very exciting, innovative and novel technique."